A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer

NCT01017874 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Pemetrexed
DRUG: Cisplatin
DRUG: Gefitinib
DRUG: Gefitinib

Sponsor

Eli Lilly and Company